NASDAQ$LNTH
Lantheus Holdings, Inc · Q4 2024 earnings
Q4 2024 earnings · · Before market open · Investor relations
Briefing
Lantheus reported solid revenue growth driven by radiopharmaceutical sales despite a GAAP net loss for Q4 2024.
Lantheus reported worldwide revenue of $391.1 million for Q4 2024, a 10.5% increase compared to the same period in 2023. PYLARIFY achieved record net sales, but the company posted a GAAP net loss of $11.8 million for the quarter. Adjusted earnings per share were $1.59, reflecting continued growth in radiopharmaceuticals.
- Worldwide revenue of $391.1 million, up 10.5% year-over-year.
- GAAP net loss of $11.8 million for the quarter.
- Sales of PYLARIFY reached $266.0 million, up 15.7%.
- Free cash flow increased 41.1% to $141.4 million.
Headline financials
Revenue & EPS history
Lantheus · Revenue · Quarterly
$391M
Revenue by segment
Lantheus · $76.9M total across 2 segments · Q3 2020
- DEFINITY$55.4M—72.1%
- TechneLite$21.5M—27.9%
Forward guidance
For 2025, Lantheus expects revenue between $1.545 billion and $1.610 billion, with adjusted fully diluted EPS in the range of $7.00 to $7.20.
Tailwinds
- Revenue projected to reach up to $1.610 billion.
- Adjusted EPS expected to be as high as $7.20.
- Continued focus on expanding the radiopharmaceutical portfolio.
- Strong pipeline with multiple strategic acquisitions planned.
- Enhanced cash flow position with over $900 million in cash.
Headwinds
- Ongoing GAAP losses impacting bottom line.
- Decreased revenue from strategic partnerships.
- Higher operating expenses reported for the quarter.
- Market volatility impacting investment performance.
- Potential challenges in securing regulatory clearances for acquisitions.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q4 2024
+4.2%
Avg return
Earnings day
+5.2%
Avg return
5 days after
+10.2%
Avg return
30 days after
51%
23 / 45 earnings
Positive
+63.0%
Q2 2016
Best reaction
-23.2%
Q3 2024
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +5.6% | +11.7% | +17.2% | |
| Q4 2025 | -0.4% | +4.1% | -1.7% | |
| Q3 2025 | -6.2% | -6.7% | +10.6% | |
| Q1 2025 | -23.1% | -24.2% | -22.2% | |
| Q4 2024 | +16.5% | +18.5% | +20.1% | |
| Q3 2024 | -23.2% | -26.9% | -22.6% | |
| Q2 2024 | -10.2% | -9.8% | -3.0% | |
| Q1 2024 | +12.1% | +12.8% | +21.4% | |
| Q4 2023 | +16.9% | +20.4% | +4.1% | |
| Q3 2023 | -2.7% | -1.6% | +11.7% | |
| Q2 2023 | -7.5% | -13.9% | -17.7% | |
| Q1 2023 | +14.0% | +17.9% | +7.5% | |
| Q4 2022 | +24.3% | +27.0% | +39.8% | |
| Q3 2022 | -12.0% | -17.2% | -11.1% | |
| Q2 2022 | +3.5% | +5.1% | +3.4% | |
| Q1 2022 | +11.6% | +12.7% | +19.0% | |
| Q4 2021 | +61.6% | +70.3% | +72.9% | |
| Q3 2021 | +16.6% | +21.5% | +6.9% | |
| Q2 2021 | +7.5% | +6.5% | +2.1% | |
| Q1 2021 | -5.7% | -7.2% | +3.7% | |
| Q4 2020 | -5.0% | -6.9% | +0.7% | |
| Q3 2020 | +0.3% | +7.6% | +22.2% | |
| Q2 2020 | -14.2% | -19.4% | -14.1% | |
| Q1 2020 | -14.0% | -9.4% | -2.1% | |
| Q4 2019 | +1.2% | -3.5% | -21.7% | |
| Q3 2019 | +4.1% | +6.4% | +4.9% | |
| Q2 2019 | -21.3% | -19.9% | -24.2% | |
| Q1 2019 | -5.1% | +3.8% | -1.0% | |
| Q4 2018 | +18.8% | +29.1% | +35.4% | |
| Q3 2018 | +10.2% | +18.8% | +40.8% | |
| Q2 2018 | -7.6% | -6.6% | +11.4% | |
| Q1 2018 | -2.5% | -14.7% | -20.4% | |
| Q4 2017 | -22.5% | -17.2% | -21.0% | |
| Q3 2017 | +19.3% | +17.9% | +16.8% | |
| Q2 2017 | -16.0% | -6.8% | -5.1% | |
| Q1 2017 | +13.1% | +1.5% | +25.0% | |
| Q4 2016 | +28.6% | +33.9% | +25.9% | |
| Q3 2016 | +9.8% | +1.7% | +6.4% | |
| Q2 2016 | +63.0% | +63.9% | +155.4% | |
| Q1 2016 | -6.2% | — | — | |
| Q1 2015 | -6.2% | — | — | |
| Q4 2015 | +17.1% | — | — | |
| Q3 2015 | +27.6% | — | — | |
| Q4 2014 | -1.3% | — | — | |
| Q2 2015 | -1.3% | — | — | |
| Q2 2014 | — | — | — | |
| Q4 2013 | — | — | — | |
| Q3 2013 | — | — | — | |
| Q2 2013 | — | — | — | |
| Q4 2012 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro